期刊文献+

增生性玻璃体视网膜病变增生膜中基质金属蛋白酶及其抑制剂的表达 被引量:2

Expression of matrix metalloproteinases and its inhibitors in proliferative vitreoretinal membranes
下载PDF
导出
摘要 目的研究增生性玻璃体视网膜病变(proliferative vitreoretinopathy,PVR)增生膜中基质金属蛋白酶(matrix metalloproteinases,MMP)及其抑制剂(tissue inhibitors of ma-trix metalloproteinases,TIMP)的表达。方法采用免疫组织化学技术的SP法,检测PVR增生膜和正常尸眼神经视网膜标本中MMP-2、MMP-9和TIMP-1的表达,光镜观察染色结果。结果41例PVR增生膜标本HE染色切片光镜下可见视网膜色素上皮(retinal pig-ment epithelial,RPE)细胞、神经胶质细胞、成纤维细胞、巨噬细胞等细胞成分,它们被大量细胞外基质所包绕。视网膜前膜中以RPE细胞为主要增生细胞,视网膜下膜中以神经胶质细胞为主要增生细胞。免疫组织化学染色结果显示:(1)25例PVR增生膜标本表达MMP-2,11例PVR增生膜标本表达MMP-9,14例PVR增生膜标本表达TIMP-1;(2)22例视网膜前膜标本表达MMP-2,3例视网膜下膜标本表达MMP-2,差异有显著性(P<0·05);(3)正常尸眼神经视网膜标本中未检测到MMP-2、MMP-9及TIMP-1的表达。结论细胞外基质与PVR增生膜的形成关系密切,MMP-2、MMP-9及TIMP-1在PVR形成过程中发挥重要作用,通过合理地调控MMP和TIMP的平衡,为预防和治疗PVR提供可能性理论依据。 Objective To examine the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the membranes of proliferative vitreoretinopathy(PVR). Methods The expression of MMP-2,MMP-9 and TIMP-1 in PVR membranes and normal cadaverie nervotm retina were examined by SP method of immunohistochemical technology. The results were observed by optical microscope. Results The retinal pigment epithelial (RPE) cells,nettroglial cells,fibroblasts,maerophage were seen and surrounded by extracellular matrix in 41 cases of PVR membranes stained by HE. RPE cells were main proliferative cells in epiretinal membranes, while nettroglial cells in subretinal membranes. The results of immunohistochemical methods showed that: ( 1 ) MMP-2 was expressed in 25 cases of PVR membranes,while MMP-9 in 11 cases,TIMP-1 in 14 cases;(2)MMP-2 was expressed in 22 cases of epiretinal membranes and 3 cases of subretinal membranes,there was significant difference( P 〈 0.05 ) ; ( 3 ) The expression of MMP-2, MMP-9 and TIMP-1 wash't detected in normal cadaverie retinas. Conclusion Extracellutar matrix has a close relationship with formation of PVR membranes, and MMP-2 ,MMP-9 and TIMP-1 play an important roles in formation of PVR membranes. By controlling the balance of MMPs and TIMPs reasonably may provide a possible theory in preventing and curing PVR.
出处 《眼科新进展》 CAS 2007年第6期424-428,共5页 Recent Advances in Ophthalmology
关键词 增生性玻璃体视网膜病变 增生膜 基质金属蛋白酶 基质金属蛋白酶组织抑剂 免疫组织化学技术 proliferative vitreoretinopathy proliferative membranes matrix metalloproteinases tissue inhibitors of matrix metalloproteinases immunohistochemical technology
  • 相关文献

参考文献12

  • 1The Retina Society Terminology Committee.The classification of retinal detachment with proliferative vitreoretinopathy[J].Ophthalmology 1983;90(1):121-125.
  • 2Ryan SJ.The Pathophysiology of proliferative vitreoretinopathy and its management[J].Am J Ophthalmol 1985;100(1):188-193.
  • 3Ivana KK,Jorge GA.Mechanisms in proliferative vitreoretinopathy[J].Ophthalmol Clin N Am 2002;15(1):81-86.
  • 4Campochiaro PA,Jendan JA.The extracellular matrix of human retinal pigment epithelial cell in vivo and its synthesis in vitro[J].Invest Ophthalmol Vis Sci 1986;27(11):615-621.
  • 5Webster L.Prodominance of MMP-1 and MMP-9 in epiretinal and subretinal membranes of proliferative vitreoretinopathy[J].Exp Eye Res 1999;68(1):91.
  • 6Gonzalez-Avila G,Mendez D,Lozano D.Role of retinal detachment subretinal fluid on extracellular matrix metabollish[J].Ophthalmologica 2004;218(1):49-56.
  • 7刘雪霞,吴海洋,陶海.MMP/TIMP系统与玻璃体视网膜疾病的研究进展[J].眼科新进展,2007,27(2):155-158. 被引量:4
  • 8Kon CH,Occleston NL,Charteris D,Daniels J,Avlward GW,Khaw PT,et al.A prospective study of matrix metallopreteinases in proliferative vitreoretinopathy[J].Invest Ophthalmol Vis Sci 1998;39(8):1524.
  • 9刘海霞,张文华.基质金属蛋白酶及其抑制剂与角膜[J].国外医学(眼科学分册),1999,23(6):361-367. 被引量:9
  • 10Ozerdem U,Mach-Hofacre B,Cheng L,Chaidhawangul S,Keefe K,McDermott CD.Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy[J].Curr Eye Res 2000;20(6):447-453.

二级参考文献40

  • 1赵平,谢喜玮,于华军.卡托普利防治糖尿病小鼠视网膜病变的实验研究(英文)[J].国际眼科杂志,2004,4(3):387-390. 被引量:2
  • 2孟自军,曾水清.联合应用软骨素酶和基质金属蛋白酶3诱导产生玻璃体后脱离的实验研究[J].中华眼科杂志,2004,40(9):625-631. 被引量:14
  • 3徐毅.-[J].国外医学:眼科学分册,1996,20(5):312-312.
  • 4Visse R,Nagase H.Matrix metalloproteinases and tissue inhibitors of metalloproteinases:structure,function,and biochemistry[J].Circ Res 2003;92(8):827-839.
  • 5Vaughan-Thomas A,Gibert SJ,Duance VC.Eleavated levels of proteolytic enzymes in the aging human vitreous[J].Invest Ophthalmol Vis Sci 2000;41(11):3299-3304.
  • 6Bishop PN,Holmes DF,Kadler KE.Age-related change on the surface of vitreous collagen fibrils[J].Invest Ophthalmol Vis Sci 2004;45(6):1041-1046.
  • 7Trese MT.Enzymatic-assisted vitrectomy[J].Eye 2002;16(4):365-368.
  • 8Sebag J.Is pharmacologic vitreolysis Brewing[J]?Retina 2002;22(1):1-3.
  • 9Ivana KK,Jorge GA.Mechanisms in proliferative vitreoretinopathy[J].Ophthalmol Clin N Am 2002;15(1):81-86.
  • 10Gonzalez-Avila G,Mendez D,Lozano D.Role of retinal detachment subretinal fluid on extracellular matrix metabolism[J].Ophthalmologica 2004;218(1):49-56.

共引文献99

同被引文献28

  • 1罗文,严宏.增生性玻璃体视网膜病变不同病理阶段的调控因素[J].眼科新进展,2005,25(3):286-288. 被引量:4
  • 2姜燕荣,王凯,姜宁,黎晓新.外伤性复发性视网膜脱离玻璃体手术的效果[J].眼外伤职业眼病杂志,2006,28(2):84-86. 被引量:14
  • 3Nagasaki H,Shinagawa K,Mochizuki M. Risk factors for proliferative vitreoretinopathy[ J ]. Prog Retin Eye Res 1998 ; 17 ( 1 ) : 77-98.
  • 4Sharma T, Gopal L, Shanmugam MP, Bhende PS, Agrawal R, Badrinath SS, et al. Management of recurrent retinal detachment in silicone oil-filled eyes [J]. Retina 2002; 22 ( 2 ) : 153-157.
  • 5Cardillo JA, Stout JT, LaBree L, Azen SP, Omphroy L, Cui JZ. Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome [ J ]. Ophthalmology 1997;104(7) :1166-1173.
  • 6Mittra RA, Mieler WF. Controversies in the management of open-globe injuries involving the posterior segment [ J ]. Surv Ophthalmol 1999 ;44(3 ) :215-225.
  • 7The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy [J]. Ophthalmology 1983 ;90 ( 2 ) : 121-125.
  • 8Heimann K, Weidemann P. Cologne classification of proliferative vitreoretinopathy: Proliferative vitreoretinopathy [ M ]. Heideberg: Kaden Verlag; 1989 : 22-23.
  • 9Wagner PJ,Lang GK. Mechanical ocular trauma[J]. Curr Opin Ophthalmol 1996;7(4) :57-64.
  • 10Wu Q,Liu W. The diagnoses and treatment of traumatic retinal detachment[ J] . Yanke Xuebao 1996;12(4) :193-195.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部